ATE412409T1 - Verfahren zur reinigung von pravastatin - Google Patents

Verfahren zur reinigung von pravastatin

Info

Publication number
ATE412409T1
ATE412409T1 AT04811862T AT04811862T ATE412409T1 AT E412409 T1 ATE412409 T1 AT E412409T1 AT 04811862 T AT04811862 T AT 04811862T AT 04811862 T AT04811862 T AT 04811862T AT E412409 T1 ATE412409 T1 AT E412409T1
Authority
AT
Austria
Prior art keywords
pravastatin
purification
provides
present
purifying pravastatin
Prior art date
Application number
AT04811862T
Other languages
English (en)
Inventor
Vilmos Keri
Istvan Melczer
Original Assignee
Teva Gyogyszergyar Zartkoeruee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Gyogyszergyar Zartkoeruee filed Critical Teva Gyogyszergyar Zartkoeruee
Application granted granted Critical
Publication of ATE412409T1 publication Critical patent/ATE412409T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/48Separation; Purification; Stabilisation; Use of additives
    • C07C67/52Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/48Separation; Purification; Stabilisation; Use of additives
    • C07C67/56Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
AT04811862T 2003-11-24 2004-11-23 Verfahren zur reinigung von pravastatin ATE412409T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52549403P 2003-11-24 2003-11-24
US53231403P 2003-12-22 2003-12-22
US55416504P 2004-03-18 2004-03-18

Publications (1)

Publication Number Publication Date
ATE412409T1 true ATE412409T1 (de) 2008-11-15

Family

ID=34637188

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04811862T ATE412409T1 (de) 2003-11-24 2004-11-23 Verfahren zur reinigung von pravastatin

Country Status (12)

Country Link
US (2) US7425644B2 (de)
EP (2) EP1641447B1 (de)
JP (2) JP2007512366A (de)
AT (1) ATE412409T1 (de)
CA (1) CA2546377A1 (de)
DE (3) DE04811862T1 (de)
ES (1) ES2251894T3 (de)
HR (1) HRP20080686T3 (de)
PL (1) PL1641447T3 (de)
PT (1) PT1641447E (de)
TW (1) TWI319707B (de)
WO (1) WO2005051372A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005121062A2 (en) * 2004-06-09 2005-12-22 Ranbaxy Laboratories Limited Process for the preparation of pravastatin
JP4775727B1 (ja) * 2010-08-17 2011-09-21 貞宏 平山 印刷物の微小マークによる一般人が容易にできる真贋判定方法
JP6218287B2 (ja) * 2013-01-29 2017-10-25 学校法人産業医科大学 シスプラチン耐性がんの治療のためのHMG−CoA還元酵素阻害薬の使用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4319039A (en) 1979-06-15 1982-03-09 Merck & Co., Inc. Preparation of ammonium salt of hypocholesteremic fermentation product
US4346277A (en) * 1979-10-29 1982-08-24 Eaton Corporation Packaged electrical heating element
DK149080C (da) 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
DE3682557D1 (de) 1985-09-13 1992-01-02 Sankyo Co Hydroxy-ml-236b-derivate, deren herstellung und anwendung.
US4857547A (en) 1988-01-07 1989-08-15 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4857522A (en) 1988-03-21 1989-08-15 E. R. Squibb & Sons, Inc. Derivatives of pravastatin for inhibiting cholesterol biosynthesis
US5180589A (en) 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
US5099035A (en) 1989-02-27 1992-03-24 E. R. Squibb & Sons, Inc. Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
US5140012A (en) 1990-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing pravastatin
US5202029A (en) 1991-03-13 1993-04-13 Caron Kabushiki Kaisha Process for purification of hmg-coa reductase inhibitors
US5157025A (en) 1991-04-01 1992-10-20 E. R. Squibb & Sons, Inc. Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
CZ292612B6 (cs) 1992-05-20 2003-11-12 Abbott Gmbh & Co. Kg Peptid s protirakovinnou aktivitou, jeho použití a farmaceutický prostředek s obsahem takového peptidu
NZ250609A (en) 1992-12-28 1995-07-26 Sankyo Co Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
SI9300303A (en) 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
IL112639A0 (en) 1994-03-11 1995-05-26 Bristol Myers Squibb Co A pharmaceutical composition containing pravastin
US5616595A (en) 1995-06-07 1997-04-01 Abbott Laboratories Process for recovering water insoluble compounds from a fermentation broth
US5942423A (en) 1995-06-07 1999-08-24 Massachusetts Institute Of Technology Conversion of compactin to pravastatin by actinomadura
ATE189804T1 (de) 1995-08-03 2000-03-15 Dsm Nv Selektives verfahren zur deacylierung von acylverbindungen
US5883109A (en) 1996-07-24 1999-03-16 Bristol-Myers Squibb Company Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
US6165757A (en) 1997-02-20 2000-12-26 Dsm N.V. Nitrogen feed in statin fermentation
KR100210482B1 (ko) 1997-04-10 1999-07-15 김종인 스트렙토마이세스엑스포리아투스(streptomycesexfoliatus)yj-118과이를이용한프라바스타틴나트륨의제조방법
AU9264598A (en) 1997-08-22 1999-03-16 Gist-Brocades B.V. Statin production by fermentation
SI9800046A (sl) 1998-02-18 1999-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti
JP2931971B1 (ja) 1998-02-23 1999-08-09 利夫 佐藤 プラバスタチンの製造法
SI20072A (sl) 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze
SI20305A (sl) 1999-08-06 2001-02-28 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Kristali natrijeve soli pravastatina
CZ20012761A3 (cs) 1999-02-03 2002-05-15 Institute For Drug Research Ltd. Mikrobiální způsob výroby pravastatinu
US6682913B1 (en) 1999-02-03 2004-01-27 Institute For Drug Research Ltd. Microbial process for preparing pravastatin
HUP9902352A1 (hu) 1999-07-12 2000-09-28 Gyógyszerkutató Intézet Kft. Eljárás pravasztatin mikrobiológiai előállítására
DE60031447T2 (de) * 1999-11-30 2007-08-30 Teva Gyogyszergyar Zartköruen Muködo Reszvenytarsasag Verfahren zur rückgewinnung von statinverbindungen aus einer fermentationsbrühe
WO2001081611A1 (en) 2000-04-27 2001-11-01 Biocon India Limited A novel process for the manufacture and purification of compactin
SK5232003A3 (en) * 2000-10-05 2004-06-08 Biogal Gyogyszergyar Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same
JP3463881B2 (ja) * 2002-08-06 2003-11-05 三共株式会社 プラバスタチン又はその薬理上許容される塩の単離・精製方法
TW589178B (en) * 2003-02-21 2004-06-01 China Chemical & Pharmaceutica A novel industrial process to obtain pravastatin sodium of high purity

Also Published As

Publication number Publication date
HRP20080686T3 (en) 2009-03-31
PL1641447T3 (pl) 2009-04-30
DE04811862T1 (de) 2006-03-02
CA2546377A1 (en) 2005-06-09
WO2005051372A2 (en) 2005-06-09
TWI319707B (en) 2010-01-21
EP1641447A2 (de) 2006-04-05
DE202004020671U1 (de) 2005-12-08
ES2251894T3 (es) 2009-04-01
TW200518745A (en) 2005-06-16
JP2007512366A (ja) 2007-05-17
JP2009161542A (ja) 2009-07-23
ES2251894T1 (es) 2006-05-16
US20050113446A1 (en) 2005-05-26
WO2005051372A3 (en) 2005-08-11
PT1641447E (pt) 2008-12-10
DE602004017461D1 (de) 2008-12-11
EP1641447B1 (de) 2008-10-29
US7425644B2 (en) 2008-09-16
US20080300305A1 (en) 2008-12-04
EP2033636A1 (de) 2009-03-11

Similar Documents

Publication Publication Date Title
ATE369201T1 (de) Verfahren zur reinigung von synthesegas
ATE540962T1 (de) Extraktive verfahren zur aufreinigung von sucralose
DE50115863D1 (de) Verfahren zur regelung der fahrstabilität
DE602005001156D1 (de) Verfahren und vorrichtung zur reinigung von nukleinsäuren
ATE298326T1 (de) Verfahren zur epoxidierung von olefinen
DE50213709D1 (de) Verfahren zur bereitstellung von zielführungshinweisen
DE60114348D1 (de) Verfahren zur Reinigung von Gasen
DE602004023757D1 (de) Methode zur reinigung von fsh
DE50303241D1 (de) Verfahren zur bereitstellung von abwesenheitsinformation
DE50206295D1 (de) Verfahren zur Aufbereitung von Industrieabwässern
DE502004001216D1 (de) Verfahren zur aufreinigung von blausäure
ATE286041T1 (de) Verfahren zur industriellen herstellung von 5- amino-3-carboxymethyl-4-cyano-2- thiphencarboxydimethylester
ATE297909T1 (de) Verfahren zur epoxidierung von olefinen
DE60214629D1 (de) Verfahren zur Zersetzung von Michael-Addukten
DE60113157T2 (de) Verbessertes verfahren zur herstellung von simvastatin
DE60104535D1 (de) Verfahren zur hydroxylation von aliphatischen verbindungen
ATE387367T1 (de) Verfahren und system zur unterstützung des betriebs von arbeitszügen
ATE412409T1 (de) Verfahren zur reinigung von pravastatin
DE60331527D1 (de) Gereinigtes lasofoxifen und verfahren zur aufreinigung von racemischem lasofoxifen durch umkristallisieren
DE50302124D1 (de) Verfahren zur verbesserung des regelverhaltens von kraftfahrzeugregelungssystemen
DE60109565D1 (de) Verfahren zur Reinigung von Schwefel
DE10290206D2 (de) Verfahren zur Regelung der Fahrstabilität
DE60328693D1 (de) Verfahren zur oxadimierung von carbonylverbindungen
DE50313666D1 (de) Verfahren zur regelung der fahrstabilität
ATE322478T1 (de) Verfahren zur reinigung von caprolactam

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1641447

Country of ref document: EP